The agreement to initiate the investment of Lodz Toxicology Centre was signed on 12 July 2022.

The agreement was entered into between Central University Hospital Medical University of Lodz and the contractors of the investment i.e., the following consortia:  WARBUD S.A., the Consortium Leader, and BUDOMAL Rafał Leśniak Ltd. the Consortium Partner.

The event was participated by:

• Karol Młynarczyk, Deputy Governor of Lodz
• Adam Wieczorek, Vice-President of Lodz
• Prof. Radzisław Kordek, Rector of MUL
• Prof. Lucyna Woźniak, Vice Rector for Research Strategy and International Relations
• Prof. Adam Antczak, Vice Rector for Clinical Affairs and Research Management
• Prof. Waldemar Machała, Vice Rector for Military Health Service
• Jacek Grabowski PhD, Chancellor of MUL
• Michał Marek MA, Deputy Chancellor for Investment and Technical Affairs
• Monika Domarecka PhD, Director of the Central University Hospital (CUH) MUL
• Prof. Paweł Ptaszyński, Rector’s Plenipotentiary for Campus of Clinical and Didactic Centre, Deputy Director for Medical and Organisational Affairs of CUH
• Prof. Anna Krakowiak, specialist in toxicology
• Lech Wąsowski, Procuration holder for Warbud S.A., Director for the Southern Region
• Rafał Leśniak, CEO of BUDOMAL, Renovation and Construction Company

Lodz Toxicology Centre (LTC) will be constructed in the premises of the Campus of Clinical and Didactic Centre Medical University of Lodz. The initiative will take advantage of part of Building A-2, bridged to the adjacent multi-storey Building A-1, where multispecialists health care is provided using Central University Hospital services and infrastructure. (Currently, the building is undergoing the construction work under the longer-term project: Construction Stage 2 of Clinical and Didactic Centre Medical University of Lodz).

The LTC usable area of 3.121,5 m² is projected to include:

• construction of Acute Poisoning Department (Department of Toxicology)
  • a total of projected beds: 15
• expansion of Department of Anaesthesiology and Intensive Care
  • the number of already created beds:  4
• construction of an insulated ambulance ramp intended for LTC patients
• construction of Diagnostic Laboratory

Part of the Acute Poisoning Department (Department of Toxicology) connected directly with patients’ admission which includes, among others, decontamination rooms, treatment room, resuscitation and treatment room, diagnostic analysis labs, antidote bank, will be located on the ground floor of Building A-2

The remaining part of the Acute Poisoning Department will occupy the first floor and this section will include patient rooms (two 3-bed rooms, two 2-bed ones, an isolation room, one-bed and three-bed isolation rooms as well as an examination room, a psychologist’s surgery, a treatment room, a hyperbaric chamber). Both parts of the Department situated on different floors will be conveniently linked by two stairwells and a hospital lift. The project also involves the expansion of the Department of Anaesthesiology and Intensive Care by inclusion of a 4-unit intensive care room and nursing care units. The expanded section will be incorporated in the currently functioning Department of Anaesthesiology and Intensive Care Central University Hospital.

The underground storey of Building A-2 is intended for Diagnostic Laboratory which will provide a wide range of services in toxicological diagnostics among others.

The solutions agreed upon in the design of LTC are consistent with the latest achievements in medicine and they will enable the application of the highest standards of treatment in compliance with the applicable provisions of law.